• Return to Headlines

Medtronic Plc: 52-Week High Recently Eclipsed (MDT)

By James Quinn

Shares of Medtronic Plc (NYSE:MDT) traded at a new 52-week high today of $109.89. Approximately 943,000 shares have changed hands today, as compared to an average 30-day volume of 4.7 million shares.

Medtronic, PLC develops therapeutic and diagnostic medical products. The Company's principal products include those for bradycardia pacing, tachyarrhythmia management, atrial fibrillation management, heart failure management, heart valve replacement, malignant and non-malignant pain, and movement disorders. Medtronic's products are sold worldwide.

Based on a current price of $109.89, Medtronic Plc is currently 16.5% above its average consensus analyst price target of $91.71. The stock should find initial support at its 50-day moving average (MA) of $102.50 and further support at its 200-day MA of $93.72.

Over the past year, Medtronic Plc has traded in a range of $81.66 to $109.89 and is now at $109.89, 35% above that low. The 200-day and 50-day moving averages have moved 0.33% higher and 0.72% higher over the past week, respectively.

SmarTrend recommended that subscribers consider buying shares of Medtronic Plc on May 3rd, 2019 as our proprietary SmarTrend analytics indicated a new Uptrend was in progress when shares hit $89.49. Since that recommendation, shares of Medtronic Plc have risen 21.4%. We continue to monitor MDT for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately.

Keywords: 52 week high/lows medtronic plc

Ticker(s): MDT